Covered recipient · General Payments record
LALISA P WADE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$594.74
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $434.77 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $256.30 | 10 |
| Axsome Therapeutics, Inc. | $88.52 | 2 |
| Novo Nordisk AS | $38.40 | 2 |
| ABBVIE INC. | $22.44 | 1 |
| Kyowa Kirin, Inc. | $14.74 | 1 |
| ITI, Inc. | $14.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.44 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108367840 | CMS |
| Amgen Inc. | $45.60 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117408711 | CMS |
| Amgen Inc. | $22.53 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711582 | CMS |
| Amgen Inc. | $42.57 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117408713 | CMS |
| Amgen Inc. | $101.84 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711584 | CMS |
| Amgen Inc. | $8.57 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711570 | CMS |
| Amgen Inc. | $3.76 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711572 | CMS |
| Amgen Inc. | $7.61 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711574 | CMS |
| Amgen Inc. | $2.02 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711576 | CMS |
| Amgen Inc. | $4.15 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711578 | CMS |
| Amgen Inc. | $17.65 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117711580 | CMS |
| Axsome Therapeutics, Inc. | $13.99 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148381672 | CMS |
| Axsome Therapeutics, Inc. | $74.53 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148381674 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14.37 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143623234 | CMS |
| Kyowa Kirin, Inc. | $14.74 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127052503 | CMS |
| Novo Nordisk Inc | $16.70 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100298057 | CMS |
| Novo Nordisk Inc | $21.70 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100530231 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.